» Articles » PMID: 38789981

Epidemiological Characteristics of Neuroendocrine Neoplasms in Beijing: a Population-based Retrospective Study

Overview
Publisher Biomed Central
Specialty Public Health
Date 2024 May 24
PMID 38789981
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The incidence of neuroendocrine neoplasms (NENs) is rising rapidly worldwide. However, there are few reports on these heterogeneous diseases in China. Our study aimed to explore the epidemiological characteristics of NENs in Beijing.

Methods: We conducted a retrospective cohort study using population-based cancer surveillance data in Beijing, China. All data were extracted from the Beijing Cancer Registry with incidence dates from 1 January 1998 to 31 December 2018; the follow-up period was through 31 December 2021. Segi's world standard population was used to estimate the age-standardized rate. Survival was estimated using the Kaplan-Meier method.

Results: From 1998 to 2018, the incidence of NENs in Beijing initially showed a significant increasing trend, from 1.07/100,000 to 3.53/100,000; this began to plateau after 2013. The age-specific incidence rate increased with age and peaked in the age group 70-74 years. The incidence in men was significantly higher than that in women (4.41/100,000 vs. 1.69/100,000). The most common sites of NENs were the lung (2.38/100,000) and rectum (0.14/100,000). Most NENs were diagnosed at a late stage. We found that NENs originating from the lung had worse overall survival than extrapulmonary NENs, and male patients had worse survival than female patients.

Conclusions: This study retrospectively analyzed the epidemiological characteristics of NENs in Beijing from 1998 to 2018. Our findings provide a reference regarding the epidemiological statistics of NENs in Beijing to contribute to the prevention, diagnosis, and treatment of these specific tumors.

Citing Articles

Gastroenteropancreatic Neuroendocrine Tumors: Does Tumor Location Affect Prognosis?.

Ozsoy M, Erol C, Aydemir M, Baysal H, Buyuker F, Seneldir H Arch Iran Med. 2025; 28(1):29-39.

PMID: 40001327 PMC: 11862391. DOI: 10.34172/aim.33366.

References
1.
Cheung R . Racial and socioeconomic disparities in malignant carcinoid cancer cause specific survival: analysis of the surveillance, epidemiology and end results national cancer registry. Asian Pac J Cancer Prev. 2014; 14(12):7117-20. DOI: 10.7314/apjcp.2013.14.12.7117. View

2.
Jalbert J, Casciano R, Meng J, Brais L, Pulgar S, Berthon A . Treatment Patterns and Health Resource Use Among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated at a Tertiary Referral Center. Oncologist. 2020; 25(4):e644-e650. PMC: 7160404. DOI: 10.1634/theoncologist.2019-0691. View

3.
Gosain R, Ball S, Rana N, Groman A, Gage-Bouchard E, Dasari A . Geographic and demographic features of neuroendocrine tumors in the United States of America: A population-based study. Cancer. 2019; 126(4):792-799. PMC: 7870292. DOI: 10.1002/cncr.32607. View

4.
Fan J, Zhang Y, Shi S, Chen Y, Yuan X, Jiang L . A nation-wide retrospective epidemiological study of gastroenteropancreatic neuroendocrine neoplasms in china. Oncotarget. 2017; 8(42):71699-71708. PMC: 5641082. DOI: 10.18632/oncotarget.17599. View

5.
Abdel-Rahman O, Fazio N . Sex-Based Differences in Prognosis of Patients With Gastroenteropancreatic-Neuroendocrine Neoplasms: A Population-Based Study. Pancreas. 2021; 50(5):727-731. DOI: 10.1097/MPA.0000000000001821. View